|
Target Audience
Medical, surgical, and radiation oncologists, as well as allied oncology healthcare professionals who treat breast cancer.
Needs Assessment
Significant improvements have occurred in the management of breast cancer over the past decade. One of the most widely studied approaches to the field of cancer, particularly breast cancer, is treatment strategies incorporating new agents and novel combinations. This is based on an extensive search of the literature in the public domain. Despite these advances, uncertainties remain. With novel pharmacological agents and treatment strategies, the decision-making process for oncology healthcare professionals involved in the treatment of breast cancer is challenging, thereby requiring in-depth knowledge of current clinical and experimental data for the appropriate integration of new therapeutics into clinical practice. Because of this, healthcare professionals caring for patients with breast cancer need to understand the basis for treatment approaches likely to change clinical practice in the next few years, as well as the preclinical and clinical data supporting the development and integration of these therapies into practice. As such, this program has been developed to provide a comprehensive overview of recent advances in the treatment of breast cancer, treatment guidelines, and ongoing clinical trials. The didactic presentation will be combined with discussions on controversial topics in breast cancer management, thus allowing for an interactive exchange of critical clinical information.
Learning Objectives
Upon completion of this educational activity, participants should be better able to:
- Discuss the clinical implications of the results of pivotal clinical trials, including early phase trials, that have potential to impact the use of therapies in breast cancer
- Discuss data regarding the safety profiles of therapeutic approaches in the treatment of breast cancer, either alone or in combination with currently accepted standard therapies, and propose methods for side effect management and maintenance of quality of life
- Evaluate novel therapies and/or regimens that provide the best patient outcomes and whether current guidelines provide similar recommendations
- Review and compare clinical outcomes and endpoints in order to interpret and establish which clinical trials are the most meaningful to improving patient care
|
